EPISODE · May 13, 2026 · 23 MIN
Pharmaniaga Post-PN17 Betting Big on Biopharma
from The Breakfast Grille · host BFM Media
Pharmaniaga officially exited PN17 status in March, having taken three years to complete its regularisation plan. The firm is now vying to become the most valuable pharmaceutical company in Malaysia by 2030 leveraging on its ongoing government concession in logistics and biopharma manufacturing capabilities. We catch-up with Managing Director Dato’ Zulkifli Jafar to find out how he intends to achieve this goal.See omnystudio.com/listener for privacy information.
NOW PLAYING
Pharmaniaga Post-PN17 Betting Big on Biopharma
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m